SUMMARY An 8-week-old infant presented with Arizona hinshawii meningitis and bacteraemia. The child responded well to the administration of parenteral ampicillin and chloramphenicol. However, chloramphenicol was discontinued after one day of therapy, and A. hinshawii was recultured from the cerebrospinal fluid on the fifth day. Chloramphenicol therapy was restarted and the patient had an uneventful recovery. This report is the first description of A. hinshawii meningitis and should alert clinicians to the possible occurrence of this infection in endemic areas.
Arizona hinshawii has been described as a rare cause of disease in humans.' Its spectrum resembles closely that of Salmonella species. Although salmonella meningitis has been reported,2 Arizona species have not previously been known to cause meningitis. In this report we describe a case of meningitis due to A. hinshawii with particular reference to host factors, clinical course, and the organism's antibiotic sensitivities.
Case report
An 8-week-old white girl was admitted to hospital because of a 24-hour history of high fever, vomiting, progressive lethargy, and one generalised tonic seizure. She was the normal 3-3 kg product of fullterm uncomplicted pregnancy, labour, and delivery. She Hospital management included immediate administration of intravenous ampicillin at 400 mg/kg per day in six divided doses, and intravenous chloramphenicol at 100 mg/kg per day in four divided doses. Fluids were restricted to threefourths of maintenance requirements, and intramuscular phenobarbital was begun for persistent minor motor seizures. She improved markedly during the first 6 hours and was afebrile and alert by day 3. As the organism was sensitive to ampicillin and chloramphenicol, therapy with chloramphenicol was discontinued after 24 hours, at which time a repeat lumbar puncture showed 100/,ul (0-1 x 109/1) white blood cells (91 % segmented neutrophils), protein 185 mg/100 ml (1-85 g/l), and glucose 22 mg/100 ml (1 22 mmol/l), and there was no 848 growth on culture.
On the fourth day of her course, chloramphenicol was restarted at 100 mg/kg per day intravenously. Repeat lumbar puncture on transfer to Children's Hospital National Medical Center on day 5 showed 141/gl (0.14 x 109/l) white blood cells (33 % segmented neutrophils), glucose 40 mg/100 ml (2-22 mmol/l), protein 148 mg/100 ml (1-48 g/l), lactic acid 18 mg/100 ml (199 mmol/l), a negative limulus test and Gram stain, and a culture positive for the same species of Arizona. Stool cultures taken from the patient on day 5 of therapy showed no pathogens. Stool cultures obtained from all immediate members of the family were also negative. On day 9, five days after restarting chloramphenicol and with uninterrupted ampicillin therapy, repeat lumbar puncture was sterile with 48/,iI (0.048 x 109/l) white blood cells (all lymphocytes), glucose 46 mg/100 ml (2-55 mmol/l), protein 97 mg/100 ml (0.97 g/l), lactic acid 17 mg/100 ml (1-89 mmol/l), and limulus negative.
Her clinical course subsequent to transfer was notable for steady improvement in the level of activity, with no fever or seizures. After transfer she received an additional 21 days of intravenous ampicillin, 400 mg/kg per day in four divided doses, and intravenous chloramphenicol, 75 mg/kg per day in four divided doses. After 48 hours off antibiotics she remained afebrile and asymptomatic and had a spinal tap which showed 8/,ul (0.008 x 109/l) white blood cells (all lymphocytes), glucose 42 mg/100 ml (2-33 mmol/l), protein 46 mg/100 ml (0-46 g/l), lactic acid 6 mg/100 ml (0.67 mmol/l), negative limulus and Gram stain, and no growth on culture. She was discharged in good condition.
On follow-up examination four weeks after discharge, the patient had remained asymptomatic, was gaining weight, and achieving developmental milestones normally. Neurological examination was completely normal and an electroencephalogram (EEG) was within normal limits for her age.
Discussion
Previously described cases of human disease caused by A. hinshawii are most notable for a high incidence of localised infection in immunocompromised hosts.' The three cases reported in children included an age range of 2 to 7 years, all having an underlying disease such as sickle cell anaemia or Letterer-Siwe disease. Young infants, such as the one described here, may be considered immunocompromised hosts in terms of their susceptibility to bacterial meningitis. This is probably based on diminished barriers between bowel flora and bloodstream, increased meningeal permeability,34 and relatively poor opsonisation and leucocyte bactericidal activity, particularly against invasive encapsulated organisms. It appears that this case represents a relatively immunocompromised host's response to exposure to a pathogenic organism, which may be widespread in the South Pacific.
Arizona species are known to occur naturally in reptiles and poultry and possibly in many other animals.' It is similar to Salmonella species in its capacity for producing an asymptomatic gastrointestinal carrier state in humans,5 a fact which further suggests that it is a fairly common food contaminant. It is also recognised that food sanitation techniques are considerably less advanced in developing countries. It is therefore highly probable that this patient's illness resulted from exposure to a contaminated food source.
In a review of salmonella meningitis, They reported 58% mortality and 440% long-term morbidity, where survival and fever sequelae correlated significantly with a cerebrospinal fluid protein of 500 mg/100 ml (5.0 mmol/l). The findings of CSF protein at most of 217 mg/100 ml (2.17 g/l), of normal neurological examination and developmental status, and normal EEG all suggest a favourable prognosis in this case. However, longterm follow-up, especially for hearing and speech, will be recommended for this child. 
